Curis, Inc. logo

Curis, Inc.

NASDAQ:CRIS

Overview | Financials
Company Name Curis, Inc.
Symbol CRIS
Currency USD
Price 5.86
Market Cap 35,036,647
Dividend Yield 0%
52-week-range 0.38 - 17.49
Industry Biotechnology
Sector Healthcare
CEO Mr. James E. Dentzer
Website https://www.curis.com

An error occurred while fetching data.

About Curis, Inc.

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin

Related Stocks

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.24 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Mustang Bio, Inc. logo

Mustang Bio, Inc.

MBIO

0.254 USD

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.6 USD

Neuronetics, Inc. logo

Neuronetics, Inc.

STIM

0.945 USD

Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc.

VRCA

1.85 USD

Movano Inc. logo

Movano Inc.

MOVE

0.36 USD

Lumos Pharma, Inc. logo

Lumos Pharma, Inc.

LUMO

3.7 USD

Financials

Numbers are in millions USD

Numbers are in millions USD